Assyro AI

Orange Book product · Brand (NDA)

LUMIFY PRESERVATIVE FREE

BRIMONIDINE TARTRATE

Brand (NDA)NDA 218424OTC BAUSCH AND LOMB INC

At a glance

Apr 19, 2024

Approved

Brand (NDA)

Application

Not listed

TE code

3

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Apr 19, 2024

    2 yr 2 mo ago

  2. Today

  3. Patent 11596600 expires

    Listed method-of-use patent (U-2222) expiration.

    Jul 27, 2029

    in 3 yr 2 mo

  4. Patent 8293742 expires

    Listed method-of-use patent (U-2222) expiration.

    Jul 14, 2030

    in 4 yr 2 mo

  5. Patent 9259425 expires

    Listed method-of-use patent (U-2222) expiration.

    Jul 14, 2030

    in 4 yr 2 mo

Pharmaceutical detail

Active ingredient

BRIMONIDINE TARTRATE

Strength

0.025%

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

TE code

Not listed

Application

NDA 218424

Product number

001

Marketing status

OTC

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (3)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
11596600Jul 27, 2029in 3 yr 2 mo
U-2222
8293742Jul 14, 2030in 4 yr 2 mo
U-2222
9259425Jul 14, 2030in 4 yr 2 mo
U-2222
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.